Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s site revision label changed from v3.8.0 to v3.8.1, with no indicated change to the clinical trial information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check29 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are adopting “Super Intelligence” (SI) terminology in place of “Artificial Intelligence” (AI).SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check43 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check63 days agoChange DetectedThe history list now shows a new revision label v3.7.0, replacing the prior v3.6.6. This reflects a new version of the page's record history interface.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.